On behalf of the 2026 CGA-IGC Annual Meeting Planning Committee, we thank you for submitting your work for presentation. The online submission and evaluation process will be administered by the Kenes M+ Annual Meeting Organizing Secretariat.
All abstracts must be submitted online through the abstract submission system. Abstracts that are sent via e-mail or fax will not be included in the abstract assessment process by the Scientific Committee.
Abstract submission deadline:
Monday, June 1, 2026 - 23:59 MDT (UTC-6)
Please take a moment to read the below guidelines before proceeding to submit your abstract.
Abstract Submission Guidelines
- All abstracts must be written in English.
- All abstracts must be submitted online through the abstract submission system. Abstracts that are sent via e-mail will not be included in the abstract review process.
- Use acronyms only when necessary and define all abbreviations and concepts in your abstract at first use.
- Always make sure to check the final abstract with the system’s preview function before submission and edit or replace as necessary. It is the authors’ responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
- Since there will be no editing process on the abstracts, the authors are requested to avoid any typing errors, mis-ordering of the authors, wrong spelling/writing about the institutions, etc.
- The submitting and presenting authors are required to ensure that all co-authors are aware of the content of the abstract before submission.
- Only studies based on new and not-previously-published results can be submitted.
- All abstracts will initially be reviewed and will either be accepted or rejected by the Meeting Planning Committee. Meeting Planning Committee reserves the right to determine whether an abstract submission is accepted as an oral or a poster presentation.
- If you re-open your abstract, please make sure to check that all author affiliations are correct and all questions are answered completely before re-submitting.
- Only the abstracts of presenting authors who have completed their registrations and paid their registration fees by the registration deadline for abstract presenters (July 31, 2026) will be included in the Scientific Program and the abstract publications in the Familial Cancer Journal.
- Withdrawal of abstracts is only accepted if notified in writing and subsequently confirmed by the CGA-IGC Annual Meeting Organizing Secretariat.
- By submitting an abstract, the authors consent to give CGA-IGC 2026 permission to publish their abstracts in the Familial Cancer Journal.
Publication in Familial Cancer Journal
CGA-IGC annual meeting abstracts are published in the Familial Cancer Journal.
Please visit the links to view abstracts from previous years:

Abstract Preparation and Submission on the System
STEP 1 – Title, Submission Type, and Topic
- Title must be in UPPERCASE and limited to 25 words. An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.
- Use only generic drug names. Brand, product or company names must not be used in the abstract title or text. CGA-IGC reserves the right to replace any brand name with a generic name.
- Type / Topic: A type and main topic (see here) that is relevant for your abstract must be selected during the submission process. Meeting Planning Committee reserves the right to change the category during the abstract assessment process.
- Presentation type: During the submission please indicate your preferred presentation type (oral or poster). Meeting Planning Committee will make the final determination of the presentation type according to the requirements of the scientific program.
As usual, abstracts will be considered either for:
- Podium (Oral) or Poster
- Poster Only
STEP 2 – Authors and Institution Information
- The institution(s) of the authors should be indicated fully with the “department” and “institution” names while avoiding any abbreviations such as Dept., Univ., Inst., Hosp., etc.
- The department and institution details, city and country should be written with lower case while the initials of each word should be in capitals.
- Please make sure to include the City, State and Country information at the end for each institution.
- Enter each affiliation only once.
- First, middle and last names of all the authors must be fully indicated correctly and in the right order. Please pay attention to matching the institutions from the dropdown menu to the right authors, and make sure that you select the “presenting author” correctly from the Author List.
- In this step, you can add additional authors and define their roles in the abstract. The presenter could be the same person as the submitter - when setting up a new abstract, you are the submitter by default. Simply tick the presenter box next to the name of the author who shall receive author role.
- To add an author, click 'Add author':
- A new window will pop up. Enter the name of your co-author in the field provided and click the 'Search' button. If the respective name appears, the author is already entered in database.
- Author in database: If the system finds a result, please select the author by clicking on the 'Add' icon.
- Author not in database: If the system does not find any results, you can add a new author to the database by clicking on 'Add new author' button.
- Fill in all bold/mandatory fields to add a new author to the system and hit 'Save'.
- The window closes, the person appears within your list of authors.
IMPORTANT: The system allows only one presenter per submission. Please select one author as the presenter during submission.
For “How We Do It” submissions, after submission all authors will be assigned as presenters for the selected “How We Do It” submissions.
- For more detailed information please visit Abstract Help page.
STEP 3 – Keywords
- Keywords should not be included in any of the sections of the abstract body and written only in the section dedicated for keywords.
- A minimum of 1 keyword is required and maximum 6 keywords can be entered.
- You may add up to 6 keywords by pressing 'Add' after each one.
STEP 4 - Abstract Body
- Abstract body should not exceed 300 words. The title of the abstract, authors, institutions and keywords are not included in this limit, and those should not be entered in this section.
- Abstract body should consist of four sections given below:
- If you are submitting a “General Research” or “Diversity/Equity/Inclusion/Justice” abstract please submit your abstract with the structure below:
- Background and Aim
- Methods
- Results
- Conclusions
- If you are submitting a “Case reports / Case series” please submit your abstract with the structure below:
- Background and Aim
- Clinical Presentation
- Discussion
- Conclusions
- If you are submitting a “Collaborative” abstract please submit your abstract with the structure below:
- Background and Aim
- Preliminary data (if any)
- Project Plan and Timeline
- Requirements for Collaboration
- If you are submitting a "How We Do It" abstract please submit your abstract with the structure below:
- Background
- Description of Your Program
- Outcome
- Presentation Outline
- If you are submitting a “General Research” or “Diversity/Equity/Inclusion/Justice” abstract please submit your abstract with the structure below:
- Images, tables, diagrams and graphs are allowed for the abstracts. Please upload images, tables, diagrams and graphs in the system on the related section of the abstract submission system.
Please note that submitted images must strictly adhere to these guidelines, or the abstract will not be published:
- For images, the permitted file types are listed above as .jpeg, .jpg, .jpe, .gif, .png
- Name your figure files with “Fig” and the figure number, e.g., Fig1.
- Definition: Black and white graphic with no shading.
- Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
- All lines should be at least 0.1 mm (0.3 pt) wide.
- Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
- Vector graphics containing fonts must have the fonts embedded in the files.
- All tables should be submitted in image format.
STEP 5 – Abstract Questions
- At this step answer questions about profession, career level, possible award applications and simultaneous publication opportunities.
STEP 6 – Conflict of Interest Disclosure
- Authors must declare if they have any conflict of interests in their abstract.
- Each abstract submission must include one learning objective that clearly defines the intended educational outcome. Please use only one behavioral verb from the categories below to ensure clarity and specificity.
IMPORTANT: “How We Do It” submitters must include one learning objective per presenter that clearly defines the intended educational outcome.
For guidance on writing effective learning objectives, refer to: AAMC Learning Objectives Guide.
Suggested Behavioral Verbs:
- Remembering: Define, Identify, List, State, Reproduce
- Understanding: Classify, Indicate, Match, Select, Summarize
- Applying: Apply, Examine, Generalize, Illustrate, Record
- Analyzing: Compare, Contrast, Differentiate, Discriminate, Examine
- Evaluating: Argue, Critique, Defend, Evaluate, Judge
- Creating: Construct, Design, Formulate, Hypothesize, Plan
STEP 7 – Declarations
- Agreement with affirmation items will be needed to be able to proceed with abstract submission.
STEP 8 – Preview & Submit
- Review the abstract summary to confirm it is completed as intended.
- If there are any missing required fields, a message is displayed in red.
- Please click the button Finish Submission to submit your abstract.
After Submission
- When the submission process is finalized, you will see your abstract on your account Home page. Please be aware that the Scientific Committee will not receive “Not-Submitted Abstracts” and these therefore cannot be taken into consideration in the abstract review process.
- Please make sure to save your username and password for future use.
- You may edit your abstract up until the deadline date. Please make sure to final submit each time you edit your abstract in order to save your work. If you re-open your abstract, please make sure to check that all author affiliations are correct before re-submitting.
Abstract Preparation and Submission on the System
STEP 1 – Title, Submission Type, and Topic
- Title must be in UPPERCASE and limited to 25 words. An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.
- Use only generic drug names. Brand, product or company names must not be used in the abstract title or text. CGA-IGC reserves the right to replace any brand name with a generic name.
- Type / Topic: A type and main topic (see here) that is relevant for your abstract must be selected during the submission process. Meeting Planning Committee reserves the right to change the category during the abstract assessment process.
- Presentation type: During the submission please indicate your preferred presentation type (oral or poster). Meeting Planning Committee will make the final determination of the presentation type according to the requirements of the scientific program.
As usual, abstracts will be considered either for:
- Podium (Oral) or Poster
- Poster Only
STEP 2 – Authors and Institution Information
- The institution(s) of the authors should be indicated fully with the “department” and “institution” names while avoiding any abbreviations such as Dept., Univ., Inst., Hosp., etc.
- The department and institution details, city and country should be written with lower case while the initials of each word should be in capitals.
- Please make sure to include the City, State and Country information at the end for each institution.
- Enter each affiliation only once.
- First, middle and last names of all the authors must be fully indicated correctly and in the right order. Please pay attention to matching the institutions from the dropdown menu to the right authors, and make sure that you select the “presenting author” correctly from the Author List.
- In this step, you can add additional authors and define their roles in the abstract. The presenter could be the same person as the submitter - when setting up a new abstract, you are the submitter by default. Simply tick the presenter box next to the name of the author who shall receive author role.
- To add an author, click 'Add author':
- A new window will pop up. Enter the name of your co-author in the field provided and click the 'Search' button. If the respective name appears, the author is already entered in database.
- Author in database: If the system finds a result, please select the author by clicking on the 'Add' icon.
- Author not in database: If the system does not find any results, you can add a new author to the database by clicking on 'Add new author' button.
- Fill in all bold/mandatory fields to add a new author to the system and hit 'Save'.
- The window closes, the person appears within your list of authors.
IMPORTANT: The system allows only one presenter per submission. Please select one author as the presenter during submission.
For “How We Do It” submissions, after submission all authors will be assigned as presenters for the selected “How We Do It” submissions.
- For more detailed information please visit Abstract Help page.
STEP 3 – Keywords
- Keywords should not be included in any of the sections of the abstract body and written only in the section dedicated for keywords.
- A minimum of 1 keyword is required and maximum 6 keywords can be entered.
- You may add up to 6 keywords by pressing 'Add' after each one.
STEP 4 - Abstract Body
- Abstract body should not exceed 300 words. The title of the abstract, authors, institutions and keywords are not included in this limit, and those should not be entered in this section.
- Abstract body should consist of four sections given below:
- If you are submitting a “General Research” or “Diversity/Equity/Inclusion/Justice” abstract please submit your abstract with the structure below:
- Background and Aim
- Methods
- Results
- Conclusions
- If you are submitting a “Case reports / Case series” please submit your abstract with the structure below:
- Background and Aim
- Clinical Presentation
- Discussion
- Conclusions
- If you are submitting a “Collaborative” abstract please submit your abstract with the structure below:
- Background and Aim
- Preliminary data (if any)
- Project Plan and Timeline
- Requirements for Collaboration
- If you are submitting a "How We Do It" abstract please submit your abstract with the structure below:
- Background
- Description of Your Program
- Outcome
- Presentation Outline
- If you are submitting a “General Research” or “Diversity/Equity/Inclusion/Justice” abstract please submit your abstract with the structure below:
- Images, tables, diagrams and graphs are allowed for the abstracts. Please upload images, tables, diagrams and graphs in the system on the related section of the abstract submission system.
Please note that submitted images must strictly adhere to these guidelines, or the abstract will not be published:
- For images, the permitted file types are listed above as .jpeg, .jpg, .jpe, .gif, .png
- Name your figure files with “Fig” and the figure number, e.g., Fig1.
- Definition: Black and white graphic with no shading.
- Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
- All lines should be at least 0.1 mm (0.3 pt) wide.
- Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
- Vector graphics containing fonts must have the fonts embedded in the files.
- All tables should be submitted in image format.
STEP 5 – Abstract Questions
- At this step answer questions about profession, career level, possible award applications and simultaneous publication opportunities.
STEP 6 – Conflict of Interest Disclosure
- Authors must declare if they have any conflict of interests in their abstract.
- Each abstract submission must include one learning objective that clearly defines the intended educational outcome. Please use only one behavioral verb from the categories below to ensure clarity and specificity.
IMPORTANT: “How We Do It” submitters must include one learning objective per presenter that clearly defines the intended educational outcome.
For guidance on writing effective learning objectives, refer to: AAMC Learning Objectives Guide.
Suggested Behavioral Verbs:
- Remembering: Define, Identify, List, State, Reproduce
- Understanding: Classify, Indicate, Match, Select, Summarize
- Applying: Apply, Examine, Generalize, Illustrate, Record
- Analyzing: Compare, Contrast, Differentiate, Discriminate, Examine
- Evaluating: Argue, Critique, Defend, Evaluate, Judge
- Creating: Construct, Design, Formulate, Hypothesize, Plan
STEP 7 – Declarations
- Agreement with affirmation items will be needed to be able to proceed with abstract submission.
STEP 8 – Preview & Submit
- Review the abstract summary to confirm it is completed as intended.
- If there are any missing required fields, a message is displayed in red.
- Please click the button Finish Submission to submit your abstract.
After Submission
- When the submission process is finalized, you will see your abstract on your account Home page. Please be aware that the Scientific Committee will not receive “Not-Submitted Abstracts” and these therefore cannot be taken into consideration in the abstract review process.
- Please make sure to save your username and password for future use.
- You may edit your abstract up until the deadline date. Please make sure to final submit each time you edit your abstract in order to save your work. If you re-open your abstract, please make sure to check that all author affiliations are correct before re-submitting.
Evaluation Process and Acceptance Letters
All submitted abstracts will be scored by multiple members of the Scientific Committee. While scientific merit is the most important factor in evaluating an abstract, the program will also take into account other factors such as the topic, geographic representation, etc.
While we understand that the ability of authors at some institutions to obtain leave and/or financial reimbursement for conferences is determined by the type of presentation, this will not factor into the Scientific Committee’s decision and requests to upgrade a presentation will not be considered. The decision of the Scientific Committee will be final.
Acceptance letters will be sent via e-mail by early July 2026. Relevant information about your abstract's presentation including the presentation date, time, venue, presentation number will be included in the acceptance letter.
The abstract presenting author must be registered for the meeting by July 31, 2026.
Abstracts of unregistered presenting authors who do not complete their registrations (including payment) by this deadline will be removed from the final program and all relevant publications, including the Familial Cancer Journal.
Thank you for submitting your work for consideration. We look forward to welcoming you to the CGA-IGC Annual Meeting in Denver, CO, on November 2 – 4, 2026.
Please contact us directly should you have any specific enquiries.
Kenes M+, Scientific Program Coordinator
Cagla Avcioglu, cavcioglu@kenes.com
Evaluation Process and Acceptance Letters
All submitted abstracts will be scored by multiple members of the Scientific Committee. While scientific merit is the most important factor in evaluating an abstract, the program will also take into account other factors such as the topic, geographic representation, etc.
While we understand that the ability of authors at some institutions to obtain leave and/or financial reimbursement for conferences is determined by the type of presentation, this will not factor into the Scientific Committee’s decision and requests to upgrade a presentation will not be considered. The decision of the Scientific Committee will be final.
Acceptance letters will be sent via e-mail by early July 2026. Relevant information about your abstract's presentation including the presentation date, time, venue, presentation number will be included in the acceptance letter.
The abstract presenting author must be registered for the meeting by July 31, 2026.
Abstracts of unregistered presenting authors who do not complete their registrations (including payment) by this deadline will be removed from the final program and all relevant publications, including the Familial Cancer Journal.
Thank you for submitting your work for consideration. We look forward to welcoming you to the CGA-IGC Annual Meeting in Denver, CO, on November 2 – 4, 2026.
Please contact us directly should you have any specific enquiries.
Kenes M+, Scientific Program Coordinator
Cagla Avcioglu, cavcioglu@kenes.com

